Market Cap 27.83M
Revenue (ttm) 15.03M
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.12%
Debt to Equity Ratio 0.00
Volume 143,000
Avg Vol 904,640
Day's Range N/A - N/A
Shares Out 5.89M
Stochastic %K 3%
Beta 7.01
Analysts Sell
Price Target $4.22

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Address:
7921 Southpark Plaza, Suite 210, Littleton, United States
nassermahashir
nassermahashir Jul. 30 at 4:36 AM
$VVOS after huge collapse this needs another 6 months to recover all the way to 2’s
0 · Reply
nassermahashir
nassermahashir Jul. 29 at 8:05 PM
$VVOS it’s not over $2 next ..
0 · Reply
indepth1
indepth1 Jul. 29 at 7:48 PM
$VVOS @JL_TradeZ @DougieFreshPicks Incannex's FDA clearance for Phase 3 IHL-42X sleep apnea trial represents significant advancement for potential first-in-class Oral Therapy.✅️ (OSA)—a condition affecting an estimated one billion people globally > > No Approved Oral pharmaceutical Therapy !< < Incannex has received FDA authorization to advance their lead candidate IHL-42X into Phase 3 clinical trials for obstructive sleep apnea. ✅️ ✅️ Phase 3 represents a significant regulatory milestone as the company transitions from Phase 2 to pivotal Phase 3 studies. The trial design demonstrates strategic efficiency by maintaining a U.S.-ONLY Approach, which offers several operational advantages:✅️ ✅️ FDA very likely to * *FAST TRACK Phase 3 🎯 * * .= Expedited review to facilitate development of drugs that treat a Serious or life-threatening condition and fill an UNMET Medical Need.= FDA Fast Track designation. 🚀 🎯 1. Single regulatory oversight (FDA only)✅️ 2.Continuity of CRO and clinical operations teams 3.Simplified logistics for trial materials 4.Leveraging existing infrastructure from Phase 2 to Phase 3 trail. TIA Know DD details about $VVOS members. 🚀 🎯
0 · Reply
Bumpkaboo
Bumpkaboo Jul. 29 at 5:40 PM
0 · Reply
indepth1
indepth1 Jul. 29 at 5:38 PM
$VVOS @JL_TradeZ @DougieFreshPicks Still in UPTREND ✅️ 🚀 What maximum fibonacci percent retracement of total up trend from $2.00 on 6-9 '25 to $ 7.95 0n 7-11-'25 for $VVOS to FAILURE POINT ($4.35 closing price) in up total trend from $2.00 ? Maximum Fibonacci percent retracement of the total uptrend from $2.00 on 6-9-2025 to $7.95 on 7-11-2025 for $VVOS is 61%% for Uptrend Failure.✅️ ✅️ This would represent a complete reversal of the Uptrend, to( New Down trend ) ✅️ ✅️ Understanding Fibonacci Retracement:✅️ Fibonacci retracement is a technical analysis tool that uses horizontal lines to indicate areas of support at key Fibonacci levels before the 🎯 Price Resumes its Original UP Trend. 🚀 🎯 ✅️ Retracement levels act as likely Support levels during an uptrend (or resistance levels during a downtrend), where the price likely Reverse direction to UP again.🎯 Support Point =$4.40 for $VVOS Calculation for $VVOS: ✅️ Maximum Retracement: A 61% retracement means the price would retrace 61% distance of the total uptrend, returning to the $4.37🎯 Important Note: ✅️ 🚀Re-Buyer $VVOS at $4.43 on 7-29 p.m. < <. Fibonacci retracement levels of -$61% is very helpful in identifying probable support for $VVOS at $4.40 on 7-29 TIA for timely T/A knowledge of Support Point!🎯
0 · Reply
Idiotinvestur
Idiotinvestur Jul. 29 at 4:51 PM
1 · Reply
CroatoanCapital
CroatoanCapital Jul. 29 at 4:48 PM
$VVOS Revisiting the mystery public market buyer: Dawei Luo and his wholly-owned British Virgin Islands registered Space Star Holding Ltd. Info on either the person or the entity is scarce. Dawei Luo is a citizen of the PRC. He purchased 8.5% of Vivos stock in the open market, or 572,000 shares, sparking the run up to almost $8. What is the angle here? Putting the pieces together, I think there's a possibility that Vivos strikes a deal with a Chinese or Asia-based distributor to sell Vivos products in China. Vivos is already in Dubai, Australia, UK. Perhaps this new large investor is affiliated with an entity that will be introducing Vivos in China. Sleep apnea is highly prevalent in China and Vivos would be an ideal solution in such a huge market.
3 · Reply
Mrcocoloco
Mrcocoloco Jul. 29 at 4:21 PM
$VVOS Time to reload!!!🟢 Time to accumulate!!! 🟢
1 · Reply
CroatoanCapital
CroatoanCapital Jul. 29 at 4:10 PM
$VVOS Adding more here. Good spot for a turnaround.
0 · Reply
nassermahashir
nassermahashir Jul. 29 at 3:58 PM
$VVOS they said its overbought come on man!! now its 4.4 😆😆 Garbage never change
0 · Reply
Latest News on VVOS
Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 15, 2025, 7:31 PM EDT - 2 months ago

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 12:18 AM EDT - 4 months ago

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:31 PM EST - 9 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript


Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Closes $4 Million Private Placement


Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Reverse Stock Split


nassermahashir
nassermahashir Jul. 30 at 4:36 AM
$VVOS after huge collapse this needs another 6 months to recover all the way to 2’s
0 · Reply
nassermahashir
nassermahashir Jul. 29 at 8:05 PM
$VVOS it’s not over $2 next ..
0 · Reply
indepth1
indepth1 Jul. 29 at 7:48 PM
$VVOS @JL_TradeZ @DougieFreshPicks Incannex's FDA clearance for Phase 3 IHL-42X sleep apnea trial represents significant advancement for potential first-in-class Oral Therapy.✅️ (OSA)—a condition affecting an estimated one billion people globally > > No Approved Oral pharmaceutical Therapy !< < Incannex has received FDA authorization to advance their lead candidate IHL-42X into Phase 3 clinical trials for obstructive sleep apnea. ✅️ ✅️ Phase 3 represents a significant regulatory milestone as the company transitions from Phase 2 to pivotal Phase 3 studies. The trial design demonstrates strategic efficiency by maintaining a U.S.-ONLY Approach, which offers several operational advantages:✅️ ✅️ FDA very likely to * *FAST TRACK Phase 3 🎯 * * .= Expedited review to facilitate development of drugs that treat a Serious or life-threatening condition and fill an UNMET Medical Need.= FDA Fast Track designation. 🚀 🎯 1. Single regulatory oversight (FDA only)✅️ 2.Continuity of CRO and clinical operations teams 3.Simplified logistics for trial materials 4.Leveraging existing infrastructure from Phase 2 to Phase 3 trail. TIA Know DD details about $VVOS members. 🚀 🎯
0 · Reply
Bumpkaboo
Bumpkaboo Jul. 29 at 5:40 PM
0 · Reply
indepth1
indepth1 Jul. 29 at 5:38 PM
$VVOS @JL_TradeZ @DougieFreshPicks Still in UPTREND ✅️ 🚀 What maximum fibonacci percent retracement of total up trend from $2.00 on 6-9 '25 to $ 7.95 0n 7-11-'25 for $VVOS to FAILURE POINT ($4.35 closing price) in up total trend from $2.00 ? Maximum Fibonacci percent retracement of the total uptrend from $2.00 on 6-9-2025 to $7.95 on 7-11-2025 for $VVOS is 61%% for Uptrend Failure.✅️ ✅️ This would represent a complete reversal of the Uptrend, to( New Down trend ) ✅️ ✅️ Understanding Fibonacci Retracement:✅️ Fibonacci retracement is a technical analysis tool that uses horizontal lines to indicate areas of support at key Fibonacci levels before the 🎯 Price Resumes its Original UP Trend. 🚀 🎯 ✅️ Retracement levels act as likely Support levels during an uptrend (or resistance levels during a downtrend), where the price likely Reverse direction to UP again.🎯 Support Point =$4.40 for $VVOS Calculation for $VVOS: ✅️ Maximum Retracement: A 61% retracement means the price would retrace 61% distance of the total uptrend, returning to the $4.37🎯 Important Note: ✅️ 🚀Re-Buyer $VVOS at $4.43 on 7-29 p.m. < <. Fibonacci retracement levels of -$61% is very helpful in identifying probable support for $VVOS at $4.40 on 7-29 TIA for timely T/A knowledge of Support Point!🎯
0 · Reply
Idiotinvestur
Idiotinvestur Jul. 29 at 4:51 PM
1 · Reply
CroatoanCapital
CroatoanCapital Jul. 29 at 4:48 PM
$VVOS Revisiting the mystery public market buyer: Dawei Luo and his wholly-owned British Virgin Islands registered Space Star Holding Ltd. Info on either the person or the entity is scarce. Dawei Luo is a citizen of the PRC. He purchased 8.5% of Vivos stock in the open market, or 572,000 shares, sparking the run up to almost $8. What is the angle here? Putting the pieces together, I think there's a possibility that Vivos strikes a deal with a Chinese or Asia-based distributor to sell Vivos products in China. Vivos is already in Dubai, Australia, UK. Perhaps this new large investor is affiliated with an entity that will be introducing Vivos in China. Sleep apnea is highly prevalent in China and Vivos would be an ideal solution in such a huge market.
3 · Reply
Mrcocoloco
Mrcocoloco Jul. 29 at 4:21 PM
$VVOS Time to reload!!!🟢 Time to accumulate!!! 🟢
1 · Reply
CroatoanCapital
CroatoanCapital Jul. 29 at 4:10 PM
$VVOS Adding more here. Good spot for a turnaround.
0 · Reply
nassermahashir
nassermahashir Jul. 29 at 3:58 PM
$VVOS they said its overbought come on man!! now its 4.4 😆😆 Garbage never change
0 · Reply
toro365
toro365 Jul. 29 at 3:35 PM
$VVOS Hoping for 4.25 +/- to double down
1 · Reply
ka1954
ka1954 Jul. 29 at 3:35 PM
$VVOS great timing guys. market may correct, and this will follow. piece of crap
0 · Reply
stocktrader1549
stocktrader1549 Jul. 29 at 3:33 PM
$VVOS fly by night garbage wht
0 · Reply
ka1954
ka1954 Jul. 29 at 11:38 AM
$VVOS this coming down is nonsense. most stocks i see that bottomed around 2 or 3, went up to around $10 atleast. they did a 200% big volume day and then a few % up days to make it to $10. VVOS never had a big volume, it was a slow grind. what a market
0 · Reply
skips200k
skips200k Jul. 29 at 10:48 AM
$VVOS Good old VVOS, counting shares. $4 to $8 on 8.5mil shares, excluding the 25mil share day. $8 to 4.5, on 2.2 mil shares. 2 , 13D's. Hmmm? I will side with the buy side. Very
0 · Reply
Bumpkaboo
Bumpkaboo Jul. 29 at 4:10 AM
$VVOS AI is taking over 🤖—> People lose their job ☹️—> People get stressed, eat more snacks, gains weight, can’t sleep well 😣—> More people get sleep apnea 😫 —> More people need Vivos 😤 Jk. Hopefully the world is getting better ❤️‍🩹.
0 · Reply
xbizo
xbizo Jul. 29 at 2:36 AM
$VVOS $30MM EV at 1x 2025 revenue. Near term PT is $15. That's pretty solid, but so much more possible.
1 · Reply
MythicalDragon
MythicalDragon Jul. 29 at 2:01 AM
0 · Reply
Tipsy1989
Tipsy1989 Jul. 29 at 1:41 AM
$VVOS You scared? I'm not! Here for the ride.
0 · Reply
Are_You_Experienced
Are_You_Experienced Jul. 29 at 12:33 AM
$VVOS Me, I'm buying a lot more. That is what dry powder is kept for....come to Papa!!!
0 · Reply
Are_You_Experienced
Are_You_Experienced Jul. 29 at 12:30 AM
$VVOS I don't care how good the future is with FDA and Medicare cleared coverage of cost; with nothing from investor relations, no pr, update, even some "white" bs..... sp will drop as investors move money out and invest it in some thing that will produce profit.
0 · Reply
Idiotinvestur
Idiotinvestur Jul. 28 at 11:57 PM
0 · Reply